Oncotarget is an English international open access journal. Oncotarget was established in 2010 and specializes in cancer research. Once the content is written, it is displayed on their website where anyone can quickly access the information. The chief editors of Oncotarget are Mikhail Blagosklonny and Andrei V. Gudkov. Impact Journals publish Oncotargeton weekly basis. It is a member of Committee on Publication Ethics (COPE) and follows their rules when writing the journal.
Oncotarget is peer-reviewed and mainly deals with trying to reduce effects of cancer. It does this by emphasizing on trying to educate their readers on potential targets and means of treatment that cancer patients can follow. Oncotarget seeks to use evidence based on the present and also the past. This is to ensure it gives the best results to their users. It also ensures that what it gives is accepted by health professionals. Oncotarget is also available on Dove Press.
Since its formation in 2010, Oncotarget has published approximately 370 papers which are related to oxygen. Some Oncotarget members who have been acknowledged for their study include Gregg Semenza and William Kaelin. In 2016, they discovered a pathway for oxygen sensing, and due to this, they won the Lasker award.
Oncotarget’s mission is to ensure that discoveries are shared fast. It also seeks to maximize research and make scientific results available to everyone on their website. Some of the papers which have been published by Oncotarget include E-cigarette research and Met Amplification.
E-cigarette research was conducted by Dr. IrfhanRahman and was to check on the role of E-liquid in the teeth. The discovery was that it caused a lot of harm in the teeth and gum. Cigarettes act as a catalyst and a means of entry of disease-causing microorganisms which raises the risk of getting cancer. Oncotarget, which is published by Impact Journals
MET Amplification was to check for a change in genetic material to gastric cancer. After the research, the results proved that few groups of gastric cancer reacted to MET-TKIs.
Apart from oncology, Oncotarget is also dealing with issues in cardiology, neuroscience, neuropathology, microbiology, chromosome amongst other matters. Works by writers submitted to Oncotarget should be of high quality and all their rules should be followed. Quality matters most to Oncotarget.